<?xml version='1.0' encoding='utf-8'?>
<section article="ghg" article_name="Health - General" number="24-906" title_number="24" title_name="Miscellaneous Provisions" subtitle_number="9" subtitle_name="Opioid–associated Disease Prevention and Outreach Programs">
  <level label="a">
    <level label="1">
      <text>Each Program participant shall be issued a unique identification card with a unique identification number.</text>
    </level>
    <level label="2">
      <text>The unique identification number may not be cross–indexed to any personal identifying data on the participant.</text>
    </level>
  </level>
  <level label="b">
    <text>Any information obtained by a Program that identifies Program participants, including Program records, is:</text>
    <level label="1">
      <text>Confidential;</text>
    </level>
    <level label="2">
      <text>Not open to public inspection or disclosure; and</text>
    </level>
    <level label="3">
      <text>Not discoverable in any criminal or civil proceeding.</text>
    </level>
  </level>
  <level label="c">
    <level label="1">
      <text>Notwithstanding the provisions of subsection (b) of this section, on the written consent of a Program participant, information obtained by a Program that identifies the Program participant may be released or disclosed to an individual or agency for purposes of linking to services under § 24–903(a)(6) of this subtitle.</text>
    </level>
    <level label="2">
      <text>In addition to the provisions of paragraph (1) of this subsection, if a Program participant raises the issue of participation in a Program either as a subject matter or legal defense in an administrative, civil, or criminal proceeding, the Program participant waives the confidentiality as to identity provided under subsection (b) of this section.</text>
    </level>
    <level label="3">
      <text>Substance–related treatment records requested or provided under this section are subject to any additional limitations on disclosure or re–disclosure of a medical record developed in connection with the provision of substance–related treatment services under State law or 42 U.S.C. § 290dd–2 and 42 C.F.R. Part 2.</text>
    </level>
  </level>
</section>
